правовое регулирование отношений общего образования
Главное меню:
Интересное
правовое регулирование отношений общего образования, ENJAYMO® (sutimlimab-jome) | Cold Agglutinin Disease Treatment, ENJAYMO® (sutimlimab-jome) | What is ENJAYMO?, HIGHLIGHTS OF PRESCRIBING INFORMATION - enjaymo.com, ENJAYMO® (sutimlimab-jome) | How ENJAYMO Can Help Treat CAD, ENJAYMO® (sutimlimab-jome) | ENJAYMO Dosing, ENJAYMO® (sutimlimab-jome) | What is Cold Agglutinin Disease?, ENJAYMO® (sutimlimab-jome) | Resources.
=ָt;ψ ]O 8(Q7c pN@5;dcfdi QKG5;Fዝa'jQ C>hg2VM;䕘-s슎9|{JwuDGґ;w,+vfٴ . FOc-,D0TKrx0$B2$A2&9I-3$4)QK&249I"w, ɘ;==.HXe Bb$RmEtb1A NbL\- G`_AV(8 hg9k8Z FZsxJ\S[n*fM@w]bf~hoY>SP6ފyZ>i(oYF0;AWaWzsxߺcW5y,!!Iş^UO&F)cI(q[w\0c^ -}CAm\ "F8t{ʯP3 \E(3?߅?ބFϘ*g--cG[WTƱa*@'G&H"X:qAb12Tƕ+N}_xj,HG, ENJAYMO is the first and only FDA-approved treatment for people with cold agglutinin disease (CAD) to help decrease the need for red blood cell transfusion. For U.S. Residents Only ENJAYMO Patient Solutions (1-833-223-2428) Prescribing Info. Medication Guide. HCP Website., Serious Infections: ENJAYMO is a prescription medicine that affects your immune system. ENJAYMO may lower the ability of your immune system to fight infections. ENJAYMO increases your chance of getting serious infections including those caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B..
The recommended dosage of ENJAYMO for patients with CAD is based on body weight. For patients weighing 39 kg to less than 75 kg, the recommended dose is 6,500 mg and for patients weighing 75 kg or more, the recommended dose is 7,500 mg. Administer ENJAYMO intravenously weekly for the first two weeks, with administration every two, ENJAYMO is designed to help stop hemolysis before it starts, preventing red blood cells from being destroyed. For U.S. Residents Only ENJAYMO Patient Solutions (1-833-223-2428) Prescribing Info. Medication Guide. HCP Website. About Enjaymo . What is Enjaymo. How Enjaymo works. Safety & Side Effects., The ENJAYMO dosing schedule is designed to provide a continuous level of medicine. ENJAYMO is given as an intravenous (IV) infusion weekly for the first 2 weeks, and then every 2 weeks thereafter. Your dose of ENJAYMO (either 6.5 g or 7.5 g) is based on your body weight, which your doctor will determine for you., ENJAYMO may lower the ability of your immune system to fight infections. ENJAYMO increases your chance of getting serious infections including those caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B. These serious infections may quickly become life-threatening or cause , Serious Infections: ENJAYMO is a prescription medicine that affects your immune system. ENJAYMO may lower the ability of your immune system to fight infections. ENJAYMO increases your chance of getting serious infections including those caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B., The ENJAYMO Patient Solutions Copay Program (the “Program”) is not valid for prescriptions covered, in whole or in part, under Medicare, Medicaid, VA, DoD, TRICARE® or similar federal or state programs, including any state pharmaceutical assistance programs. The Program is not valid where prohibited by law, and savings may vary depending .